For decades, cardiology has evaluated coronary artery disease (CAD) largely through the lens of luminal stenosis, or the ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
April 7, 2026 —TRiCares SAS has received approval from the U.S. Food and Drug Administration (FDA) for an ...
April 8, 2026 — Anumana, Inc. recently announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
April 6, 2026 —Stereotaxis has received U.S. Food and Drug Administration 510(k) clearance for its Synchrony system ...
March 31, 2026 — Solo Pace Inc. has announced the commercial release of the SoloPace Fusion Temporary Pacing System. The ...
March 26, 2026 —The heart’s ability to use oxygen efficiently is a critical indicator of its health, but tests to ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
March 25, 2026 — Royal Philips has launched its intuitive interventional guidance platform, IntraSight Plus, which is ...
March 10, 2026 — Medtronic has entered into a definitive agreement to acquire Scientia Vascular, a company with critical ...
March 2, 2026 — Ascend Cardiovascular has launched its re-imagined pediatric cardiology product, a comprehensive ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
Feb. 25, 2026 — Gentuity LLC, a medical technology company specializing in next-generation intravascular imaging devices ...
Feb. 12, 2026 — ACIST Medical Systems, Inc., a Bracco Group company, has announced the launch in selected markets in ...
Feb. 12, 2026 – CellProthera has acquired the transendocardial catheter originally developed by Celyad Oncology. This ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
Feb. 9, 2026 — Argá Medtech has announced positive clinical results from the BURST-AF (NCT05572047) first-in-human trial ...
Feb. 9, 2026 — Atraverse Medical presented new clinical and preclinical data at AF Symposium 2026 in Boston, further ...
Feb. 6, 2026 — Abbott has announced new clinical data from two late-breaking presentations at AF Symposium in Boston ...
April 13, 2026